Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
VERTEX PHARMACEUTICALS INC / MA | SVP, General Counsel | Common Stock | 9.61K | $4.03M | $419.07 | Aug 15, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VRTX | VERTEX PHARMACEUTICALS INC / MA | Aug 15, 2022 | 6 | -$1.14M | 4 | Aug 17, 2022 | SVP, General Counsel |
VRTX | VERTEX PHARMACEUTICALS INC / MA | Aug 10, 2022 | 1 | -$10.8K | 4 | Aug 12, 2022 | SVP, General Counsel |
VRTX | VERTEX PHARMACEUTICALS INC / MA | Aug 9, 2022 | 1 | -$284K | 4 | Aug 10, 2022 | SVP, General Counsel |
VRTX | VERTEX PHARMACEUTICALS INC / MA | May 16, 2022 | 5 | -$33.6K | 4 | May 18, 2022 | SVP, General Counsel |
VRTX | VERTEX PHARMACEUTICALS INC / MA | Apr 29, 2022 | 5 | -$33K | 4 | May 3, 2022 | SVP, General Counsel |
VRTX | VERTEX PHARMACEUTICALS INC / MA | Feb 24, 2022 | 1 | -$354K | 4 | Feb 28, 2022 | SVP, General Counsel |
VRTX | VERTEX PHARMACEUTICALS INC / MA | Feb 17, 2022 | 1 | -$166K | 4 | Feb 22, 2022 | SVP, General Counsel |
VRTX | VERTEX PHARMACEUTICALS INC / MA | Feb 10, 2022 | 1 | -$113K | 4 | Feb 14, 2022 | SVP, General Counsel |
VRTX | VERTEX PHARMACEUTICALS INC / MA | Feb 1, 2022 | 3 | $0 | 4 | Feb 3, 2022 | SVP, General Counsel |
VRTX | VERTEX PHARMACEUTICALS INC / MA | May 17, 2021 | 2 | -$24.2K | 4 | May 19, 2021 | SVP, General Counsel |